IT1284852B1 - Use of natural human alpha-interferon - in preparation of liquid medicaments for peroral administration for treating viral infections, neoplasia and immune diseases - Google Patents

Use of natural human alpha-interferon - in preparation of liquid medicaments for peroral administration for treating viral infections, neoplasia and immune diseases

Info

Publication number
IT1284852B1
IT1284852B1 ITRM960427A IT1284852B1 IT 1284852 B1 IT1284852 B1 IT 1284852B1 IT RM960427 A ITRM960427 A IT RM960427A IT 1284852 B1 IT1284852 B1 IT 1284852B1
Authority
IT
Italy
Prior art keywords
interferon
natural human
human alpha
neoplasia
preparation
Prior art date
Application number
Other languages
Italian (it)
Inventor
Renzo Brozzo
Giulio Tarro
Original Assignee
Ist Farmacoterapico It Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Farmacoterapico It Spa filed Critical Ist Farmacoterapico It Spa
Publication of ITRM960427A0 publication Critical patent/ITRM960427A0/it
Priority to IT96RM000427 priority Critical patent/IT1284852B1/en
Priority to DK97905395T priority patent/DK0886527T3/en
Priority to KR10-1998-0706297A priority patent/KR100394382B1/en
Priority to BR9707772-0A priority patent/BR9707772A/en
Priority to PT97905395T priority patent/PT886527E/en
Priority to US09/125,122 priority patent/US6884411B1/en
Priority to GEAP19974506A priority patent/GEP20012489B/en
Priority to AT97905395T priority patent/ATE205397T1/en
Priority to DE69706657T priority patent/DE69706657T2/en
Priority to EP97905395A priority patent/EP0886527B1/en
Priority to PCT/IT1997/000040 priority patent/WO1997031649A1/en
Priority to JP9530771A priority patent/JP2000506839A/en
Priority to AU22299/97A priority patent/AU722987B2/en
Priority to ES97905395T priority patent/ES2160927T3/en
Priority to EA199800770A priority patent/EA001147B1/en
Publication of ITRM960427A1 publication Critical patent/ITRM960427A1/en
Application granted granted Critical
Publication of IT1284852B1 publication Critical patent/IT1284852B1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The following are claimed: (A) use of natural human alpha -interferon for preparation of medicaments in liquid form, to be administered by the peroral route at dosages of 100-500 IU/day, for (i) therapy of viral hepatitis, or (ii) therapy of neoplasia and immunological diseases, in humans and animals; and (B) a pharmaceutical liquid composition for peroral administration, comprising natural human alpha -interferon (either from lymphoblastoid cell cultures or from lymphocyte cells) at a concentration of 100-500 IU/ml. The interferon is obtained from lymphoblastoid cell cultures or from lymphocyte cells. The medicament is administered in monodosage units of approximately 1 ml.
IT96RM000427 1996-02-28 1996-06-14 Use of natural human alpha-interferon - in preparation of liquid medicaments for peroral administration for treating viral infections, neoplasia and immune diseases IT1284852B1 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
IT96RM000427 IT1284852B1 (en) 1996-06-14 1996-06-14 Use of natural human alpha-interferon - in preparation of liquid medicaments for peroral administration for treating viral infections, neoplasia and immune diseases
DE69706657T DE69706657T2 (en) 1996-02-28 1997-02-27 PHARMACEUTICAL COMPOSITIONS CONTAINING NATURAL HUMAN ALPHA INTERFERON
PCT/IT1997/000040 WO1997031649A1 (en) 1996-02-28 1997-02-27 PHARMACEUTICAL COMPOSITIONS COMPRISING NATURAL HUMAN α-INTERFERON
BR9707772-0A BR9707772A (en) 1996-02-28 1997-02-27 Pharmaceutical compositions comprising natural human alpha-interferon
PT97905395T PT886527E (en) 1996-02-28 1997-02-27 PHARMACEUTICAL COMPOSITION THAT INCORPORATES NATURAL HUMAN ALPHA INTERFERENCE
US09/125,122 US6884411B1 (en) 1996-02-28 1997-02-27 Method of treating viral hepatitis by administration of liquid human α-interferon
GEAP19974506A GEP20012489B (en) 1996-02-28 1997-02-27 Use of Natural Human α-Interferon
AT97905395T ATE205397T1 (en) 1996-02-28 1997-02-27 PHARMACEUTICAL COMPOSITIONS CONTAINING NATURAL HUMAN ALPHA INTERFERON
DK97905395T DK0886527T3 (en) 1996-02-28 1997-02-27 Pharmaceutical compositions containing natural human alpha interferon
EP97905395A EP0886527B1 (en) 1996-02-28 1997-02-27 Pharmaceutical compositions comprising natural human alpha-interferon
KR10-1998-0706297A KR100394382B1 (en) 1996-02-28 1997-02-27 Pharmaceutical composition consisting of natural human α-interferon
JP9530771A JP2000506839A (en) 1996-02-28 1997-02-27 Pharmaceutical composition containing natural human α-interferon
AU22299/97A AU722987B2 (en) 1996-02-28 1997-02-27 Pharmaceutical compositions comprising natural human alpha-interferon
ES97905395T ES2160927T3 (en) 1996-02-28 1997-02-27 PHARMACEUTICAL COMPOSITIONS THAT INCLUDE INTERFERED NATURAL HUMAN ALPHA.
EA199800770A EA001147B1 (en) 1996-02-28 1997-02-27 Medicament for therapy of viral hepatitus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96RM000427 IT1284852B1 (en) 1996-06-14 1996-06-14 Use of natural human alpha-interferon - in preparation of liquid medicaments for peroral administration for treating viral infections, neoplasia and immune diseases

Publications (3)

Publication Number Publication Date
ITRM960427A0 ITRM960427A0 (en) 1996-06-14
ITRM960427A1 ITRM960427A1 (en) 1997-12-14
IT1284852B1 true IT1284852B1 (en) 1998-05-22

Family

ID=11404287

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96RM000427 IT1284852B1 (en) 1996-02-28 1996-06-14 Use of natural human alpha-interferon - in preparation of liquid medicaments for peroral administration for treating viral infections, neoplasia and immune diseases

Country Status (1)

Country Link
IT (1) IT1284852B1 (en)

Also Published As

Publication number Publication date
ITRM960427A0 (en) 1996-06-14
ITRM960427A1 (en) 1997-12-14

Similar Documents

Publication Publication Date Title
KR100321467B1 (en)
KR890700035A (en) Improved Interferon Therapy
AU7589587A (en) Low dosage of interferon to enhance vaccine efficiency
Borden et al. Preclinical and clinical studies of interferons and interferon inducers in breast cancer
IT1283945B1 (en) Use of natural human alpha-interferon - in preparation of liquid medicaments for peroral administration for treating viral infections, neoplasia and immune diseases
IT1284852B1 (en) Use of natural human alpha-interferon - in preparation of liquid medicaments for peroral administration for treating viral infections, neoplasia and immune diseases
HUP9902188A2 (en) Pharmaceutical compositions comprising natural human alfa-interferon
ATE205397T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING NATURAL HUMAN ALPHA INTERFERON
OA08768A (en) Treatment of AIDS virus with recombinant human alpha interferon.
MY119359A (en) Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis.
DE3686536D1 (en) OXYTOCIN AND ANTI-DAYS TO INTRODUCE BIRTH.
Sanders et al. Immune-associated toxicities induced by in vivo and in vitro exposure to interferon-alpha alone or in combination with nucleoside analogs
RU93041496A (en) γ-PL / GAMMA-PLANT / -INTERFERINFORMING AGENT
DK374388A (en) IMMUNTERAPEUTIC, ORAL INTERFERONDOSIS FORM AND PROCEDURE FOR PREPARING IT
RU92011195A (en) METHOD FOR REDUCING THE DOSE OF CHEMICAL DRUGS USED TO TREAT INFECTIOUS DISEASES IN SIMULTANEOUSLY IMPROVING THEIR THERAPEUTIC EFFICIENCY

Legal Events

Date Code Title Description
0001 Granted